Literature DB >> 1579442

Functional analysis of defined mutations in the immunoglobulin heavy-chain enhancer in transgenic mice.

A Annweiler1, U Müller, T Wirth.   

Abstract

We have analyzed the effect of defined mutations in the mouse immunoglobulin heavy-chain enhancer after introduction into the germline of transgenic mice. We have tested a mutation of the enhancer octamer motif, a double mutation of the octamer motif and the microB-site, and a triple mutation in the microE2, microE3 and microE4-sites. All constructs are expressed in the spleen of transgenic mice. Furthermore, expression is exclusively detectable in lymphoid organs and not in several nonlymphoid tissues. Whereas mutations in the microE-sites have a more pronounced effect on transgene activity in thymocytes as compared to bone marrow and spleen cells, the octamer/microB double mutation shows significantly reduced expression levels only in B-cells. Finally, our results demonstrate that the intronic heavy-chain enhancer element does not contribute to the increase steady state levels of heavy-chain mRNA after stimulation of spleen cells with LPS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1579442      PMCID: PMC312230          DOI: 10.1093/nar/20.7.1503

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  55 in total

1.  Oct-3 is a maternal factor required for the first mouse embryonic division.

Authors:  M H Rosner; R J De Santo; H Arnheiter; L M Staudt
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

2.  Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP.

Authors:  C Roman; J S Platero; J Shuman; K Calame
Journal:  Genes Dev       Date:  1990-08       Impact factor: 11.361

3.  Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo.

Authors:  A B Lassar; R L Davis; W E Wright; T Kadesch; C Murre; A Voronova; D Baltimore; H Weintraub
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

4.  Functional analysis of the murine IgH enhancer: evidence for negative control of cell-type specificity.

Authors:  T Kadesch; P Zervos; D Ruezinsky
Journal:  Nucleic Acids Res       Date:  1986-10-24       Impact factor: 16.971

5.  LR1, a lipopolysaccharide-responsive factor with binding sites in the immunoglobulin switch regions and heavy-chain enhancer.

Authors:  M Williams; N Maizels
Journal:  Genes Dev       Date:  1991-12       Impact factor: 11.361

6.  The oct-1 homeo domain contacts only part of the octamer sequence and full oct-1 DNA-binding activity requires the POU-specific domain.

Authors:  C P Verrijzer; A J Kal; P C van der Vliet
Journal:  Genes Dev       Date:  1990-11       Impact factor: 11.361

7.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

Authors:  E M Blackwood; R N Eisenman
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

8.  Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte.

Authors:  D E Sabath; H E Broome; M B Prystowsky
Journal:  Gene       Date:  1990-07-16       Impact factor: 3.688

9.  Complex pattern of immunoglobulin mu gene expression in normal and transgenic mice: nonoverlapping regulatory sequences govern distinct tissue specificities.

Authors:  T Jenuwein; R Grosschedl
Journal:  Genes Dev       Date:  1991-06       Impact factor: 11.361

10.  Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimulated mouse splenic B-cells.

Authors:  U Chen; R H Scheuermann; T Wirth; T Gerster; R G Roeder; K Harshman; C Berger
Journal:  Nucleic Acids Res       Date:  1991-11-11       Impact factor: 16.971

View more
  5 in total

1.  Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity.

Authors:  A Annweiler; M Müller-Immerglück; T Wirth
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

2.  The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development.

Authors:  J Hess; P J Nielsen; K D Fischer; H Bujard; T Wirth
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  An AP1 binding site upstream of the kappa immunoglobulin intron enhancer binds inducible factors and contributes to expression.

Authors:  J T Schanke; A Marcuzzi; R P Podzorski; B Van Ness
Journal:  Nucleic Acids Res       Date:  1994-12-11       Impact factor: 16.971

4.  Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor.

Authors:  J Hess; A Werner; T Wirth; F Melchers; H M Jäck; T H Winkler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

5.  Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities.

Authors:  P Pfisterer; A Annweiler; C Ullmer; L M Corcoran; T Wirth
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.